ArticleAntimicrobial agents and chemotherapy2018

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.

Cornelia B Landersdorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.